退行性二尖瓣修复简化:向通用人工腱索修复的演变
该研究回顾2004年至2017年847例退行性二尖瓣反流修复患者,比较切除技术时代(2004-2011,n=405)与人工腱索修复时代(2011-2017,n=438)的结局。结果显示人工腱索修复简化了手术,缩短了体外循环和阻断时间,且修复失败、卒中、感染性心内膜炎等结局与切除技术相当。
要点
- 人工腱索修复在第二时代应用于98%患者,修复率99.5%。
- 第二时代体外循环和阻断时间显著缩短。
核心结论
- 对所有退行性二尖瓣反流患者采用人工腱索修复可简化手术,并与定制切除技术相比获得等同的优异结局。
主要发现
- 总体修复成功率99.5%(843/847)。
- 瓣叶脱垂位于后叶66%、前叶8%、双叶26%。
- 时代2体外循环时间较短(97 [IQR, 76-121] 分钟 vs 109 [IQR, 92-128] 分钟,P < .001),主动脉阻断时间较短(79 [IQR, 61-99] 分钟 vs 88 [IQR, 73-106] 分钟,P < .001)。
- 出院前超声显示无或微量二尖瓣反流95%,轻度4.7%,中度0.3%。
- 手术死亡率两时代相似(0.5% vs 0.5%,P > .999);5年免于修复失败率(95.1% vs 95.5%,P = .707)、卒中(96.8% vs 95.3%,P = .538)、感染性心内膜炎(99.3% vs 99.7%,P = .604)均相似。
临床怎么用
- 人工腱索修复可作为退行性二尖瓣反流的通用、可重复的修复策略,简化手术并缩短体外循环和阻断时间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Resectional and artificial cordal repair techniques are effective strategies for degenerative mitral valve (MV) repair. However, resectional repair requires a tailored approach using various techniques, whereas cordal repair offers a simpler, easily reproducible repair. The approach described in this study approach has evolved from resectional to cordal over time, and outcomes are compared between the eras. METHODS: Clinical and echocardiographic outcomes of all patients undergoing MV repair for degenerative mitral regurgitation (MR) from January 2004 to September 2017 were reviewed. Patients were stratified by era: from January 2004 to June 2011 (era 1; n = 405), resectional techniques were used in 62% and artificial cordal techniques were used in 38%. From July 2011 to September 2017 (era 2; n = 438), artificial cordal repair was used in 98% of patients. The primary outcome was repair failure, defined as greater than moderate MR or MV reoperation. RESULTS: Of 847 patients with degenerative MR, successful repair was achieved in 843 patients (99.5% repair rate). Leaflet prolapse was posterior in 66%, anterior in 8%, and bileaflet in 26%. Cardiopulmonary bypass time and cross-clamp times were shorter in era 2 (CPB: 109 [IQR, 92-128] minutes vs 97 [IQR, 76-121] minutes; P < .001; cross-clamp: 88 [IQR, 73-106] minutes vs. 79 [IQR, 61-99] minutes; P < .001). Predismissal echocardiography demonstrated no MR or trace MR in 95%, mild MR in 4.7%, and moderate MR in 0.3% of patients. Operative mortality was similar in the eras (0.5% vs 0.5%; P > .999). The rates of 5-year freedom from repair failure (95.1% vs 95.5%; P = .707), stroke (96.8% vs 95.3%; P = .538), and endocarditis (99.3% vs 99.7%; P = .604) were similar between the eras. CONCLUSIONS: Artificial cordal repair for all patients with degenerative MR simplifies MV repair and yields equivalent, excellent outcomes compared with a tailored resectional approach.
引用
- Pasrija C, Tran D, Ghoreishi M, et al. Degenerative Mitral Valve Repair Simplified: An Evolution to Universal Artificial Cordal Repair. Ann Thorac Surg. 2019. PMID: 31863753. doi:10.1016/j.athoracsur.2019.10.068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。